ProMIS Neurosciences Inc PMN

Alzheimer’s Progression Slowed by Drug in Major Trial

[Mole101]

https://apple.news/Ak4Xc5nA5ThyiEY6_S-bP4w
 

Eisai Co. and partner Biogen Inc. said their Alzheimer’s drug lecanemab slowed the disease, becoming the first medicine to clearly blunt the progression of the most common type of dementia in a final-phase trial. 

The drug slowed cognitive decline in people with early Alzheimer’s by 27% over 18 months when compared with a placebo using a common rating scale, meeting the main goal of the trial, according to a statement from the companies on Tuesday. While modest in size, the effect was highly statistically significant. ..

[G1945V]

"The company said results from the 1,800-patient trial prove the longstanding theory that removal of sticky deposits of a protein called amyloid beta from the brains of people with early Alzheimer's can delay advance of the debilitating disease." The amyloid-beta hypothesis is still alive. Works well for PMN! G1945V

[M101]

LOL, cost of today's announcement: $US 900 million, a bargain!  https://www.fiercepharma.com/pharma/biogen-finalizes-900m-deal-settle-whistleblowers-long-running-ms-drugs-doctor-kickback-suit